Feng JM - Search Results

1

Proteasome-dependent degradation of Chk1 kinase induced by the topoisomerase II inhibitor R16 contributes to its anticancer activity.

Feng JM, Zhu H, Zhang XW, Ding J, Miao ZH. Feng JM, et al. Cancer Biol Ther. 2008 Nov;7(11):1726-31. doi: 10.4161/cbt.7.11.6728. Epub 2008 Nov 4. Cancer Biol Ther. 2008. PMID: 18787399 Free article.

2

Naphthalimides induce G(2) arrest through the ATM-activated Chk2-executed pathway in HCT116 cells.

Zhu H, Miao ZH, Huang M, Feng JM, Zhang ZX, Lu JJ, Cai YJ, Tong LJ, Xu YF, Qian XH, Ding J. Zhu H, et al. Among authors: feng jm. Neoplasia. 2009 Nov;11(11):1226-34. doi: 10.1593/neo.09986. Neoplasia. 2009. PMID: 19881958 Free PMC article.

3

Increased accumulation of hypoxia-inducible factor-1α with reduced transcriptional activity mediates the antitumor effect of triptolide.

Zhou ZL, Luo ZG, Yu B, Jiang Y, Chen Y, Feng JM, Dai M, Tong LJ, Li Z, Li YC, Ding J, Miao ZH. Zhou ZL, et al. Among authors: feng jm. Mol Cancer. 2010 Oct 11;9:268. doi: 10.1186/1476-4598-9-268. Mol Cancer. 2010. PMID: 20932347 Free PMC article.

4

Characterization of the conversion between CD133+ and CD133- cells in colon cancer SW620 cell line.

Feng JM, Miao ZH, Jiang Y, Chen Y, Li JX, Tong LJ, Zhang J, Huang YR, Ding J. Feng JM, et al. Cancer Biol Ther. 2012 Dec;13(14):1396-406. doi: 10.4161/cbt.22000. Epub 2012 Sep 6. Cancer Biol Ther. 2012. PMID: 22954703 Free PMC article.

5

Oligomannurarate sulfate sensitizes cancer cells to doxorubicin by inhibiting atypical activation of NF-κB via targeting of Mre11.

Zhang J, Xin X, Chen Q, Xie Z, Gui M, Chen Y, Lin L, Feng J, Li Q, Ding J, Geng M. Zhang J, et al. Int J Cancer. 2012 Jan 15;130(2):467-77. doi: 10.1002/ijc.26021. Epub 2011 Apr 25. Int J Cancer. 2012. PMID: 21387297

6

D11, a novel glycosylated diphyllin derivative, exhibits potent anticancer activity by targeting topoisomerase IIα.

Gui M, Shi DK, Huang M, Zhao Y, Sun QM, Zhang J, Chen Q, Feng JM, Liu CH, Li M, Li YX, Geng M, Ding J. Gui M, et al. Among authors: feng jm. Invest New Drugs. 2011 Oct;29(5):800-10. doi: 10.1007/s10637-010-9425-3. Epub 2010 Mar 25. Invest New Drugs. 2011. PMID: 20336347

7

Newly discovered angiogenesis inhibitors and their mechanisms of action.

Miao ZH, Feng JM, Ding J. Miao ZH, et al. Among authors: feng jm. Acta Pharmacol Sin. 2012 Sep;33(9):1103-11. doi: 10.1038/aps.2012.97. Epub 2012 Aug 27. Acta Pharmacol Sin. 2012. PMID: 22922347 Free PMC article. Review.

8

Design and synthesis of pyrido[3,2-α]carbazole derivatives and their analogues as potent antitumour agents.

Li B, Yue ZZ, Feng JM, He Q, Miao ZH, Yang CH. Li B, et al. Among authors: feng jm. Eur J Med Chem. 2013 Aug;66:531-9. doi: 10.1016/j.ejmech.2013.05.045. Epub 2013 Jun 6. Eur J Med Chem. 2013. PMID: 23835448

9

Differential sensitivity of RIP3-proficient and deficient murine fibroblasts to camptothecin anticancer drugs.

He JX, Wang YQ, Feng JM, Li JX, Xu L, Li XH, Wang W, Huan XJ, Jiang Y, Yu B, Chen G, Miao ZH. He JX, et al. Among authors: feng jm. Acta Pharmacol Sin. 2012 Mar;33(3):426-8. doi: 10.1038/aps.2012.1. Epub 2012 Jan 23. Acta Pharmacol Sin. 2012. PMID: 22266724 Free PMC article. No abstract available.

10

Evaluation of the clinical efficacy of Ru'ai Shuhou recipe for the prevention of lung metastases from breast cancer: a retrospective study based on propensity score matching.

Du NN, Shao SJ, Feng JM, Wan H, Wu XQ. Du NN, et al. Among authors: feng jm. Front Pharmacol. 2024 Aug 2;15:1406862. doi: 10.3389/fphar.2024.1406862. eCollection 2024. Front Pharmacol. 2024. PMID: 39156102 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters